Product Information
APLENZIN ER 522 MG TABLET is a brand product labeled by Bausch Health US LLC, priced at $212.4769 per EA under NDC 00187581230. Its NADAC has been published 512 times since Feb 11, 2015.
Strength
522 mg/1
Manufacturer
Bausch Health US LLCNDC
00187581230
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
9/17/2025
Active Ingredients
BUPROPION HYDROBROMIDEApproval Type
New Drug (NDA)
FDA Application
NDA022108On Market Since
4/23/2008
Pharmacological Classes
Price Statistics
The NADAC for APLENZIN ER 522 MG TABLET has been published 512 times since Feb 11, 2015, and over the history we have for it it has risen 295.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $212.4769 per EA |
|---|---|
| All-time high | $213.6255 (May 14, 2025) |
| All-time low | $53.7762 (Feb 11, 2015) |
| 52-week high | $212.4769 |
| 52-week low | $211.8812 |
| Median price | $142.6286 |
| Average price | $148.9563 |
| Largest weekly change | +96.7% (Feb 17, 2016) |
| Weeks tracked | 512 |
| Tracking since | Feb 11, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the bupropion hydrobromide market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of APLENZIN ER 522 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for APLENZIN ER 522 MG TABLET, manufactured by Bausch Health US LLC, is $212.4769 per EA (NDC 00187581230), effective Oct 1, 2025.
How has the price of APLENZIN ER 522 MG TABLET changed over time?
Over the history we have for it, the NADAC for APLENZIN ER 522 MG TABLET has risen 295.1%. It has been tracked across 512 weekly CMS publications since Feb 11, 2015.
What are the highest and lowest recorded NADAC prices for APLENZIN ER 522 MG TABLET?
Since Feb 11, 2015, the NADAC for APLENZIN ER 522 MG TABLET has ranged from a low of $53.7762 (Feb 11, 2015) to a high of $213.6255 (May 14, 2025), with a median of $142.6286 per EA.
Are there cheaper alternatives to APLENZIN ER 522 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of APLENZIN ER 522 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures APLENZIN ER 522 MG TABLET?
APLENZIN ER 522 MG TABLET (NDC 00187581230) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification